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A quantitative TaqMan PCR method was developed for assessing the Cryptosporidium parvum infection of in
vitro cultivated human ileocecal adenocarcinoma (HCT-8) cell cultures. This method, termed cell culture
quantitative sequence detection (CC-QSD), has numerous applications, several of which are presented. CC-
QSD was used to investigate parasite infection in cell culture over time, the effects of oocyst treatment on
infectivity and infectivity assessment of different C. parvum isolates. CC-QSD revealed that cell culture
infection at 24 and 48 h postinoculation was approximately 20 and 60%, respectively, of the endpoint 72-h
postinoculation infection. Evaluation of three different lots of C. parvum Iowa isolate oocysts revealed that the
mean infection of 0.1 N HCl-treated oocysts was only 36% of the infection obtained with oocysts treated with
acidified Hanks’ balanced salt solution containing 1% trypsin. CC-QSD comparison of the C. parvum Iowa and
TAMU isolates revealed significantly higher levels of infection for the TAMU isolate, which agrees with and
supports previous human, animal, and cell culture studies. CC-QSD has the potential to aid in the optimi-
zation of Cryptosporidium cell culture methods and facilitate quantitative evaluation of cell culture infectivity
experiments.
Ongoing challenges for the water industry are Cryptospo-
ridium detection and infectivity determination. Mouse models
have frequently been used to determine the infectivity of Cryp-
tosporidium oocysts (2, 10, 18, 20). However, animal infectivity
determination is costly and labor-intensive and requires as long
as 2 weeks to complete. Furthermore, it is not feasible for the
analysis of environmental samples. In an attempt to simplify
infectivity determination, several in vitro methods have been
developed, such as in vitro excystation and microscopic assays
evaluating the uptake or exclusion of fluorogenic dyes (3, 4)
and fluorescence in situ hybridization techniques (35). Various
PCR strategies have also been developed to assess the viability
of Cryptosporidium parvum oocysts, including the integration of
in vitro excystation (5, 9, 36) and the use of reverse transcrip-
tion-PCR for the detection of mRNA transcripts found only in
viable oocysts (24, 30).
Strategies using in vitro cell culture of C. parvum are attrac-
tive alternatives to animal infectivity testing. In most of these
assays, oocysts are stimulated to excyst by exposure to sodium
hypochlorite (bleach), bile enzymes, and/or acidic pH (7, 23,
24, 32) and are then inoculated onto in vitro-cultivated cell
culture monolayers. Sporozoites released from oocysts invade
and replicate within the intracellular environment of the cells.
After incubation, parasites are detected within the cell cultures
by a variety of techniques, including immunofluorescence mi-
croscopy (28), reverse transcription-PCR (24), and standard
PCR (7). Quantification of cell culture infection for pharma-
ceutical and disinfection studies has been achieved with an
enzyme-linked immunosorbent assay (38). Most-probable-
number formats using immunofluorescence microscopy (27,
29), colorimetric in situ hybridization (25, 37), and reverse
transcription-PCR (26) have also been described. However,
most of these methods were developed for disinfection or
inactivation studies and are used to assess differences in oocyst
infectivity over several orders of magnitude. Intrinsically, these
assays require high numbers of oocysts and labor-intensive
microscopic techniques or numerous nucleic acid extractions.
Methods that are less labor-intensive and that have greater
flexibility in the numbers of oocysts required are needed for
other types of cell culture studies.
TaqMan probe chemistry is commonly used for real-time
quantitative PCR. TaqMan quantitative PCR requires the use
of primers similar to those used in a conventional PCR; how-
ever, unlike a conventional PCR, TaqMan quantitative PCR
also requires an oligonucleotide probe labeled with 5 reporter
and 3 quencher fluorescent dyes and a thermal cycler
equipped with a fluorometer (13). During each cycle of the
PCR, if the target of interest is present, the probe specifically
anneals to the target amplicon between the forward and re-
verse primer sites. Because of the 5 nuclease activity of Taq
DNA polymerase, the probe is cleaved during the polymeriza-
tion step (PCR product formation) of the PCR, resulting in an
increase in the reporter fluorescence detected by the instru-
ment. The target signal increases in direct proportion to the
concentration of the PCR product being formed. The thresh-
old cycle (CT) is the fractional PCR cycle number at which a
significant increase in target signal fluorescence above the
baseline is first detected for a sample. By using amplification
standards consisting of known quantities of target nucleic acid
or organisms to generate a standard curve, the starting copy
number of nucleic acid targets or target organisms for each
sample can be estimated.
Recently, several real-time qualitative and quantitative PCR
methods for the detection of C. parvum oocysts have been
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described (6, 11, 12, 14). This report describes an integrated
cell culture quantitative PCR method to quantify C. parvum
cell culture infection and provides several examples of its ap-
plication to this field of research. The method developed, re-
ferred to as cell culture quantitative sequence detection (CC-
QSD), uses HCT-8 human ileocecal adenocarcinoma in vitro
cell culture in a 96-well plate format and TaqMan PCR tar-
geting the heat shock protein 70 gene (hsp70) (17) of C. par-
vum. For relative comparison of samples, a CC-QSD standard
curve was generated by inoculating HCT-8 monolayers with
different numbers of C. parvum oocysts and performing linear
regression of sample mean CT values plotted against numbers
of inoculated oocysts. Applications of the CC-QSD method
presented in this paper include evaluation of the effects of
incubation time on cell culture development of C. parvum,
evaluation of the effects of oocyst pretreatment on cell culture
infectivity, and comparison of different C. parvum isolates. The
CC-QSD method represents a less labor-intensive, more flex-
ible alternative for these types of C. parvum cell culture infec-
tion studies, as opposed to the use of techniques developed for
disinfection studies.
MATERIALS AND METHODS
Oocysts and microscopy. Purified viable C. parvum oocysts (Iowa, Harley
Moon isolate) were obtained from Waterborne, Inc. (New Orleans, La.) and the
Sterling Parasitology Laboratory (University of Arizona, Tucson). Oocysts of the
C. parvum TAMU isolate were kindly provided by Cynthia Chappell, University
of Texas Health Science Center, Houston, and propagated by the Sterling Par-
asitology Laboratory. Oocyst stocks were enumerated by immunofluorescence
assay microscopy with Dynal Spot-On-treated well slides (Dynal, A.S., Oslo,
Norway) or three-well slides (Meridian Diagnostics, Inc., Cincinnati, Ohio) and
fluorescein isothiocyanate-labeled anti-Cryptosporidium monoclonal antibody
(Waterborne, Inc.) as previously described (7).
In vitro cell culturing of C. parvum and oocyst treatment. Human ileocecal
adenocarcinoma (HCT-8; ATCC CCL-244) cells were cultivated in 96-well cell
culture microplates as previously described (7, 38). The cell monolayer in each
well of the microplate was considered a single replicate. Cell culture mainte-
nance medium consisted of RPMI 1640 medium with Glutamax (Invitrogen,
Carlsbad, Calif.), 5% fetal bovine serum (pH 7.2; HyClone, Logan, Utah), 15
mM HEPES buffer, 100,000 U of penicillin G liter1, 100 mg of streptomycin
liter1, 700 g of amphotericin B liter1, and 12.5 mg of tetracycline liter1.
Growth medium used for the in vitro development of C. parvum contained 10%
fetal bovine serum, 15 mM HEPES buffer, 50 mM glucose, 35 mg of ascorbic acid
liter1, 1.0 mg of folic acid liter1, 4.0 mg of 4-aminobenzoic acid liter1, 2.0 mg
of calcium pantothenate liter1, 100,000 U of penicillin G liter1, 100 mg of
streptomycin liter1, 700 g of amphotericin B liter1, and 12.5 mg of tetracy-
cline liter1. Twenty-four hours prior to inoculation, each microplate well was
seeded with 100 l of maintenance medium containing 5  104 HCT-8 cells.
Microplates were incubated at 37°C in a 5% CO2 humidified incubator to allow
the development of 90 to 100% confluent monolayers.
Oocysts were pretreated for cell culture by suspension in acidified (pH 2.0)
Hanks’ balanced salt solution supplemented with trypsin (type II-S porcine
pancreas; Sigma Chemical Co., St. Louis, Mo.) to a final sample concentration of
1% (wt/vol; AHBSS-trypsin) and then incubated at 37°C for 1 h with 10 s of
vortexing every 15 min (7). After incubation, an equal volume of growth medium
was added and samples were centrifuged at maximum speed in a microcentrifuge
for 2 min without the brake. Samples were then immediately and carefully
aspirated down to 50 l; 500 l of growth medium was added, and samples were
centrifuged as described above. Samples were carefully aspirated to 20 l and
resuspended in 80 l of prewarmed (37°C) growth medium containing 0.05%
trypsin. This allowed precise control over the trypsin concentration in the sample
and cell culture.
Just prior to inoculation of monolayers, 50 l of maintenance medium was
removed. Monolayers were inoculated and then incubated at 37°C in a 5% CO2
humidified incubator for 72 h prior to DNA extraction. AHBSS-trypsin-treated
viable C. parvum oocysts were used as CC-QSD positive controls (approximately
5 to 20 oocysts per cell monolayer, depending on the infectivity of the oocyst
stock), and single-cycle freeze-thaw-killed oocysts were used as CC-QSD nega-
tive controls. In addition, intact oocyst no-infection controls (IONICs) were used
to evaluate the potential background CC-QSD signals due to intact oocysts
remaining on monolayers. IONICs consisted of 5 to 250 intact viable oocysts
added to previously washed, uninoculated monolayers just prior to DNA extrac-
tion.
DNA extraction from oocysts and cell culture monolayers. After incubation,
the cell monolayers were washed five times with 200 l of PBS to remove
unexcysted oocysts. DNA was purified from HCT-8 cells with the QIAamp DNA
mini kit (QIAGEN, Valencia, Calif.) and a modified extraction protocol. Mod-
ifications included incubation of the cell monolayers with lysis buffer for 15 min
at 70 to 75°C and elution of DNA from the QIAamp DNA columns with 50 l
of 0.01 Tris-EDTA (TE), pH 8.0, at 70 to 75°C for 5 min. This method of cell
culture DNA purification was used, rather than our previous crude freeze-thaw
lysis method (7), because it provided samples with the purity required for per-
forming TaqMan quantitative PCR.
Oocyst DNA was prepared by a rapid and simple freeze-thaw extraction
procedure. Biotechnology grade Chelex 100 resin (catalog no. 143-2832; Bio-
Rad, Hercules, Calif.) was prepared as an overnight-equilibrated 1:1 volume-to-
volume slurry of resin and 1 TE buffer (pH 8.0). An equal volume of prepared
Chelex resin slurry was added to each sample with a micropipettor fitted with
large-bore (genomic) tips. For each sample, the Chelex slurry was thoroughly
resuspended and aliquots were quickly withdrawn from the reagent tube to
prevent settling of the resin and maintain a 1:1 volume-to-volume ratio of resin
and 1 TE buffer. Oocysts were lysed by eight cycles, 1 min each, of freezing in
liquid nitrogen and thawing at 94 to 98°C. Total sample volumes were 200 l or
less to ensure complete freezing and thawing during 1-min cycles.
CC-QSD. CC-QSD was performed with the Applied Biosystems 7700 or 7000
Sequence Detector (Applied Biosystems, Foster City, Calif.). PCR primers and
a TaqMan probe specific for the C. parvum hsp70 gene were used, resulting in a
346-bp product. The primer and probe sequences were as follows: forward
primer CPHSPT2F, 5 TCCTCTGCCGTACAGGATCTCTTA 3; reverse
primer CPHSPT2R, 5 TGCTGCTCTTACCAGTACTCTTATCA 3; TaqMan
probe CPHSP2P2, 5 6-carboxyfluorescein TGTTGCTCCATTATCACTCGGT
TTAGA 6-carboxytetramethylrhodamine 3. Each 100-l CC-QSD mixture con-
tained 10.0 l of 10 TaqMan A amplification buffer (Applied Biosystems); 1.5
mM MgCl2; 200 M each dATP, dTTP, dCTP, and dGTP (Amersham Pharma-
cia Biotech, Piscataway, N.J.); 200 nM each forward and reverse CPHSPT2
primer and CPHSP2P2 TaqMan probe (Synthegen, Houston, Tex.); 5.0 l of
30-mg ml1 bovine serum albumin (Sigma Chemical Co., St. Louis, Mo.); and 5.0
U of AmpliTaq Gold DNA polymerase (Applied Biosystems). Amplification
conditions were as follows: initial denaturation at 95°C for 10 min and 45 cycles
of denaturation at 95°C for 30 s and annealing at 60°C for 1 min, followed by a
final extension at 72°C for 10 min.
Purified cell culture DNA for each sample (50 l) or aliquots of Chelex-
treated oocyst DNA controls (up to 10 l) were used as templates. Molecular-
grade water was used to prepare no-template negative controls. A C. parvum
CC-QSD standard curve and equation for relative quantitation of cell culture
infection was generated on the basis of the mean background (IONICs)-sub-
tracted CT values of samples plotted against the log number of oocysts inoculated
per cell monolayer.
Data analysis and statistics. CT data for experiments were analyzed and
expressed as the percent mean and standard deviation of replicates adjusted to
experimental controls. To determine the statistical significance of results, data
were analyzed by one-way analysis of variance and post hoc Bonferroni pairwise
mean comparisons with SYSTAT 9 (SPSS Inc., Chicago, Ill.). An alpha level of
0.05 was used for all statistical tests.
RESULTS
CC-QSD quantitation of C. parvum infection in HCT-8 cell
culture. CC-QSD analysis of DNA extracted from C. parvum-
inoculated cell monolayers revealed an increase in infection
with increasing numbers of oocysts inoculated per monolayer
(Fig. 1). In most cases, analysis of variance with post hoc
Bonferroni test analysis of data revealed that CC-QSD values
were only statistically significantly different for monolayers in-
oculated with 10-fold differences in oocyst density. For exam-
ple, CC-QSD quantitation of cell culture infection differed for
monolayers inoculated with 250 and 25 oocysts (P 0.001) and












100 and 10 oocysts (P  0.047), but not for monolayers inoc-
ulated with 250 and 100 oocysts (P  0.05) or 25 and 5 oocysts
(P  0.064).
IONICs were used to investigate false CC-QSD infection
signal background that could potentially arise from intact oo-
cysts remaining on cell monolayers. A comparison of the num-
ber of CC-QSD-positive samples for AHBSS-trypsin-treated
oocysts, IONICs, and CC-QSD background signals of IONICs
is presented in Table 1. At 5 and 10 oocysts per monolayer, 3
(60%) of 5 and 4 (80%) of 5 replicates of AHBSS-trypsin-
treated oocysts tested positive by CC-QSD, respectively,
whereas all of the corresponding IONICs tested negative. At
inoculum levels of 25 to 250, all replicates of AHBSS-trypsin-
treated oocysts tested positive by CC-QSD, while the number
of IONIC replicates testing positive increased from 2 to 5 (40
to 100%), respectively. Background CC-QSD signals of ION-
ICs were low and ranged from 0 to 18% for inoculum densities
of 5 to 250 oocysts per monolayer, respectively. A CC-QSD
standard curve was generated by linear regression of mean
background-subtracted CC-QSD CT values plotted against the
number of AHBSS-trypsin-treated oocysts inoculated per cell
monolayer (Fig. 2, R2  0.98).
Development of C. parvum infection in HCT-8 cell culture.
CC-QSD was used to evaluate the increase in C. parvum in-
fection in HCT-8 cell culture from 24 to 72 h postinoculation.
CC-QSD results indicated that C. parvum infection increased
significantly over the 72-h incubation period (P  0.001). As
determined by CC-QSD, C. parvum infection at 24 and 48 h
postinoculation was approximately 20 and 60%, respectively,
of the endpoint 72 h postinoculation infection (Fig. 3). Mono-
layers inoculated with oocysts and immediately analyzed (in-
fection-negative controls) tested negative by CC-QSD.
Effects of oocyst treatment on cell culture infectivity. U.S.
Environmental Protection Agency (USEPA) methods 1622
and 1623 for the detection of Cryptosporidium in water (33, 34)
require oocysts recovered from surface water samples to be
exposed to 0.1 N HCl during the immunomagnetic separation
FIG. 1. CC-QSD quantitation of C. parvum Iowa isolate infection
in HCT-8 cell culture. Cell monolayers were inoculated with 5 to 250
AHBSS-trypsin-treated oocysts, and DNA was extracted at 72 h posti-
noculation. To evaluate the background from intact oocysts remaining
on monolayers, 5 to 250 viable oocysts were added to washed, previ-
ously uninoculated monolayers just prior to DNA extraction. Data are
means and standard deviations of five replicates.
FIG. 2. CC-QSD standard curve for C. parvum Iowa isolate infec-
tion of HCT-8 cell culture monolayers. The curve shown is based on
mean CT values of five replicates at each oocyst inoculum level.
FIG. 3. Development of C. parvum infection in HCT-8 cell culture
from 24 to 72 h postinoculation. Each cell monolayer was inoculated
with approximately 100 oocysts, and data are means and standard
deviations of three replicates and are adjusted to 100%.
TABLE 1. Background CC-QSD signal due to intact oocysts





monolayers (n  5) Mean % CC-QSD
background signalaAHBSS-trypsin-
treated oocysts IONICs
5 60 0 0
10 80 0 0
25 100 40 8
50 100 40 3
100 100 100 13
250 100 100 18
a Values derived from Fig. 1 quantitation data.












(IMS) dissociation step. To evaluate the potential effects of the
method 1622 and 1623 IMS dissociation step on C. parvum
infectivity, oocysts were resuspended in equivalent volumes of
either 0.1 N HCl or AHBSS-trypsin. The 0.1 N HCl treatment
was for 10 min at room temperature, while the AHBSS-trypsin
treatment was for 1 h at 37°C. Samples were neutralized with
1.0 NaOH, centrifuged, and resuspended in cell culture growth
medium, and cell monolayers were inoculated. CC-QSD eval-
uation of three different lots of oocysts (Fig. 4) revealed that
0.1 N HCl-treated oocysts had consistently lower HCT-8 cell
culture infectivity compared to AHBSS-trypsin-treated oocysts
(P  0.005, 0.026, and 0.024, respectively). Results indicated
that for the C. parvum Iowa isolate the mean infection ob-
tained with 0.1 N HCl-treated oocysts was only 36% of that
obtained with AHBSS-trypsin-treated oocysts.
Comparison of cell culture infectivities of different C. par-
vum isolates. The CC-QSD technique may also be useful for
the comparison of cell culture infectivity of different C. parvum
isolates. To investigate the potential application of CC-QSD
and to provide additional data on the C. parvum Iowa and
TAMU isolates previously compared for their cell culture and
mouse (26) and human infectivity (21), we compared these
isolates by CC-QSD. Lots of C. parvum Iowa and TAMU
isolate oocysts were similar in age postshedding (4 to 6 weeks)
and were propagated by the same laboratory. Repeat trials
revealed consistent and highly significant differences in the
infectivity of the isolates (Fig. 5) (P  0.003 and 0.001, respec-
tively), with the C. parvum Iowa isolate having an average of
only 33% of the C. parvum TAMU isolate cell culture infec-
tivity.
DISCUSSION
This report describes the development of a quantitative Taq-
Man PCR method (CC-QSD) for assessing the infection of an
HCT-8 human cell culture by C. parvum. Various applications
of this method were investigated, including the development of
parasite infection in cell culture over time, evaluation of the
effects of oocyst treatment on infectivity, and assessment of the
infectivity of different C. parvum isolates. The CC-QSD
method represents a less labor-intensive, more flexible alter-
native for these types of C. parvum cell culture infection stud-
ies, as opposed to the use of techniques developed for disin-
fection studies. CC-QSD is not recommended for disinfection
studies because of the likely background signal obtained at the
high oocyst inoculum densities typically used. In addition to
revealing the versatility of the CC-QSD method, results of this
study have important implications for the application and in-
terpretation of C. parvum cell culture infectivity assays.
In this study, we were interested in the relative comparison
of cell culture infection between treatment groups given inoc-
ula with similar numbers of oocyst rather than absolute quan-
titation of the number of infective oocysts per sample. There-
fore, the CC-QSD standard curve generated by linear
regression of mean background-subtracted CC-QSD CT values
plotted against the log number of AHBSS-trypsin-treated oo-
cysts inoculated per cell monolayer was sufficient. A similar
relative quantitation approach using a DNA standard curve
generated with only oocyst DNA, instead of infected cell
monolayers, was recently reported for a disinfection study (16).
The development of a universal standard curve for the abso-
lute quantitation of infective C. parvum oocysts is a significant
challenge. This is due to several factors, including (i) the vari-
ability in the actual numbers of oocysts inoculated per mono-
layer introduced by pipetting and dilution effects, (ii) the fact
that not all oocysts are infective, and (iii) the inherent biolog-
ical variability in the number and type of parasite intracellular
developmental stages and consequently the copy number of
FIG. 4. Effects of 0.1 N HCl and AHBSS-trypsin treatment of C.
parvum Iowa isolate oocysts on cell culture infectivity. HCT-8 cell
monolayers were inoculated with approximately 300 oocysts, and three
different lots of oocysts (A, B, and C) were evaluated. Data are means
and standard deviations of three replicates and are adjusted to 100%.












genomic targets. Despite the challenges facing absolute quan-
titation, our results show promise for the use of CC-QSD for
the quantitation of low numbers of infective oocysts, since
infection in monolayers inoculated with 5 and 25 oocysts dif-
fered, although not significantly (P  0.064). Greater numbers
of replicates and more precise numbers of oocysts may allow
further discrimination of inoculum levels. Our nonquantitative
cell culture PCR (CC-PCR) method has been compared to the
conventional USEPA method 1623 immunofluorescence assay
microscopy detection of naturally occurring oocysts in surface
water (19). In that study, the two methods were found to have
comparable recoveries and the data suggested that approxi-
mately 37% of the environmental oocysts detected by micros-
copy were infectious. However, because of the biological vari-
ability described above, the potential application of the CC-
QSD method presented in this paper should be limited to
qualitative (presence or absence) real-time PCR detection
rather than quantitative detection of infectious oocysts in en-
vironmental samples until further research has been per-
formed. Additional research with flow cytometry-counted oo-
cyst inocula and paired CC-QSD and microscopic detection of
infectivity is planned to better quantify Cryptosporidium cell
culture infection.
Differences in postinoculation incubation time prior to as-
sessment of infection may have a significant impact on the
amount of observed infection. Many C. parvum cell culture
studies have used 48 h postinoculation as the endpoint of
infection (16, 24, 26, 28, 29, 31). In this study, CC-QSD re-
vealed that infection at 48 h postinoculation was only 60% of
the amount of infection at 72 h postinoculation. Therefore,
incubation periods may have an effect on the ability to detect
infection, particularly with very low numbers of infectious oo-
cysts. In our previous studies using conventional CC-PCR to
assay environmental samples, an incubation period of 72 h was
used, which may have aided the detection of low numbers of
naturally occurring C. parvum oocysts (1, 7, 19). Therefore, on
the basis of our successful CC-PCR analysis of environmental
water samples and the CC-QSD data presented here, we rec-
ommend a 72-h incubation period for the CC-QSD method.
Another study reported the maintenance of C. parvum infec-
tion in HCT-8 cell culture for up to 25 days by subculturing
(15). Clearly, this is an area that deserves more investigation
for optimization of cell culture infection and detection strate-
gies.
It was previously reported that 0.1 N HCl-treated C. parvum
oocysts retained their in vitro cell culture infectivity (23), al-
though high numbers of fresh oocysts were used and infections
were not quantified. A subsequent study (22) by the same
laboratory evaluating the infectivity of oocysts by USEPA
method 1622 used in vitro excystation with bile salts rather
than the 0.1 N HCl dissociation step of method 1622. There-
fore, the effects of the 0.1 N HCl dissociation step on C.
parvum cell culture were uncertain. In the present study, the
mean infection of 0.1 N HCl-treated oocysts was only 36% of
that obtained with AHBSS-trypsin-treated oocysts. Additional
research is needed to determine whether the HCl exposure
damages oocysts or is simply an insufficient stimulus for cell
culture. However, if the observed low cell culture infectivity of
0.1 N HCl-treated oocysts is due to an adverse effect, this
would likely be more pronounced with environmentally
stressed oocysts. Therefore, the AHBSS-trypsin method is rec-
ommended over 0.1 N HCl treatment for C. parvum cell cul-
ture-based assays that rely upon IMS purification of naturally
occurring oocysts from environmental water samples.
A recent study established in vitro cell culture as an equiv-
alent to the “gold standard” mouse infectivity assay for mea-
suring the infectivity of C. parvum (26). In that study, the
authors also reported that the C. parvum TAMU isolate was
more infectious than the C. parvum Iowa isolate in HCT-8 and
Caco-2 cell culture and CD-1 mouse infectivity assays. The
authors found that the TAMU isolate had a 3.9-fold lower 50%
infectious dose (ID50) than the Iowa isolate on the basis of an
FIG. 5. Comparison of C. parvum Iowa and TAMU isolate cell
culture infectivities. Cell monolayers were inoculated with approxi-
mately 300 oocysts, and duplicate experiments were performed (A and
B). Data are means and standard deviations of five replicates and are
adjusted to 100%.












HCT-8 cell culture reverse transcription-PCR technique. Hu-
man volunteer infectivity trials have reported an ID50 of 132
oocysts for the Iowa isolate (8), compared to an ID50 of 9
oocysts for the TAMU isolate (21). In our study, CC-QSD
revealed a threefold higher level of cell culture infection for
the TAMU isolate compared to the Iowa isolate, which con-
firms and extends these previous findings. Assessment of the
infectivities of different human and animal C. parvum isolates
is critical to our understanding of Cryptosporidium biology and
ecology, and the CC-QSD method may be a useful tool for
these types of studies.
Current research efforts are aimed at the use of CC-QSD for
the optimization of oocyst pretreatment for cell culture, optimi-
zation of cell culture conditions to maximize C. parvum infection,
and the use of CC-QSD for the quantitative detection of infec-
tious C. parvum oocysts in environmental water samples.
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